3-TERT-BUTOXYCARBONYLAMINO-CYCLOBUTANE-1,1-DICARBOXYLIC ACID DIISOPROPYL ESTER, 95.0%, 100mg

Diphenyl phthalate, 99.0%, 100g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 25 m, Ø-Innen 0,53 mm, Filmd. 1,00 µm, 1 Stück

(R)-2,2'-Bis[bis(3,5-trifluoromethylphenyl)phosphino]-4,4',6,6'-tetramethoxy)-1,1'-biphenyl, ?98.0%, 500mg

2-[5-(Aminomethyl)pyridin-2-yl]-1,2- thiazinane-1,1-dione dihydrochloride, 1g

6-Methoxy-2-methylquinolin-4(1H)-one, 95.0%, 1g

7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepine hydrochloride, 97.0%, 50mg

Fmoc-N-Me-Thr-OH, 95.0%, 10g

2-(5-Chloropent-1-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

(11bR)-4-Hydroxy-2,6-bis(4-(naphthalen-1-yl)phenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 97%, 100mg

6,6-Dimethylmorpholin-3-one, 98%, 250mg

3-(Trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine, 95.0%, 1g

1-[(2-chlorophenyl)methyl]-1,4-diazepane, 95.0%, 2g